Errata “Antenatal Corticosteroids Prior to 24 Weeks' Gestation and Neonatal Outcome of Extremely Low Birth Weight Infants”

The publisher regrets an error in the table titles of Tables [1] and [2] in the above article in the American Journal of Perinatology, Volume 27, Number 1, 2010, p. 63. The correct tables appear below.

Table 1 Maternal and Delivery Characteristics of Singleton Pregnancies Delivered at 23⁰/₇ to 25⁶/₇ Weeks' Gestation

Characteristics	Steroid-Treated (n = 82)	Controls (n = 35)	p Value
Maternal age (y)	28.7 ± 7.1	26.9 ± 7.2	0.22
Black/white/other (%)	65/23/13	66/17/17	0.90
Preeclampsia (%)	9.8	2.9	0.37
Preterm labor (%)	77.8	68.9	0.61
Chorioamnionitis (%)	76.8	54.3	0.03
Premature rupture of membranes (%)	59.8	34.3	0.02
Cesarean section (%)	47.6	40.0	0.58
Gestational age at ANS dose (wk)	23.5 ± 0.5
Data expressed as percentage and mean ± standard deviation. ANS, antenatal corticosteroid.

Table 2 Antenatal Corticosteroid Exposure: Outcome of Singleton Infants at 23⁰/₇ to 25⁶/₇ Weeks' Gestation

Characteristics	Steroid-Treated (n = 82)	Controls (n = 35)	p Value
Birth weight (g)	702 ± 165	657 ± 150	0.14
Gestational age (wk)	24.3 ± 1.0	24.1 ± 1.1	0.30
Sex (% male/female)	54.9/45.1	57.1/42.9	0.84
1-min Apgar <7 (%)	68.3	88.6	0.02
5-min Apgar <7 (%)	30.5	51.4	0.03
Death before discharge (%)	29.3	62.9	<0.001
IVH (grade 1 and 2, %)	45.5	43.5	0.99
IVH (grade 3 and 4, %)	16.7	36.0	<0.05
RDS (%)	100	100	NA
PDA treated with indomethacin (%)	50.7	72.0	0.07
Sepsis (%)	60.7	52.2	0.48
NEC stage 3 and 4 (%)	0.0	6.9	0.57
Pressors (%)	54.4	64.5	0.35
ROP (stage 3–4)	32.7	23.1	0.74
BPD at 36 weeks' PCA (%)	71.9	76.9	0.99
Duration of vent (d)	51 ± 37	49 ± 21	0.80
Duration of O2 (d)	55 ± 38	53 ± 38	0.72
Length of stay (d)	117 ± 52	108 ± 24	0.41
Data expressed as percentage and mean ± SD.
PDA, patent ductus arteriosus; NEC, necrotizing enterocolitis; IVH, intraventricular hemorrhage; ROP, retinopathy of prematurity; BPD, bronchopulmonary dysplasia; PCA, postconceptional age.